Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1991-11-06
1994-02-22
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Lymphokine
530351, C07K 1500, A61K 4505
Patent
active
052884872
ABSTRACT:
Human M-CSF preparations and recombinant human M-CSF preparations against myelodysplastic syndrome, malignant tumor and hyperlipemia and auxiliary therapeutic preparations to be dosed along with platinum-complex anticancer preparations.
REFERENCES:
patent: 4847325 (1989-06-01), Shadle et al.
patent: 4929700 (1990-05-01), Halenbeck et al.
patent: 4962091 (1990-10-01), Eppstein et al.
patent: 5021239 (1991-06-01), Garnick
patent: 5084556 (1992-01-01), Brown
Motoyoshi et al., (1986), Exp. Hematol., 14:1069-1075.
Laver et al., (Sep. 20, 1989), J. Natl. Cancer Inst., 81(18):1370-1382.
Merchav et al., (1989), Br. J. Haematology, 73:158-164.
Masaoka et al., (1988), Bone Marrow Trans., 3:121-127.
Motoyashi et al., (1986), Immunobiol., 172:205-212.
Biochemical Abstracts, vol. 87, Accession No. 89-1218162, Abstract No. 62185, "Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor . . . ".
Biochemical Abstracts, vol. 87, Accession No. 89-76573, Abstract No. 40971, "Serum Cholesterol Lowering Activity of Granulocyte-Macrophage . . . ".
Garnick et al., (Apr. 1989), Clin. Res., 37(2):260A (abstract).
Shimano et al., (Aug. 5, 1990), J. Biol. Chem., 265(22):12869-12875.
Shimano et al., (May 15, 1990), Ann. N.Y. Acad. Sci., 587:362-370.
Wang et al., (1988), J. Parenteral Sci. Tech. Suppl., 42(25):51-526.
Vadhan-Raj et al., (1987), N. Engl. J. Med., 317(25):1545-1552.
Vadhan-Raj et al., (Oct. 1989), Blood, 74(5):1491-1498.
Mufson et al., (1989), Cell. Immunol., 119:182-192.
Suzu et al., (Nov. 1, 1989), Cancer Res., 49:5913-5197.
Suzu et al., (Jan. 1990), Jpn. J. Cancer Res., 81:79-84.
Munn et al., (Aug. 1989), J. Exp. Med., 170:511-526.
Munn et al., (Jul. 1990), J. Exp. Med., 172:231-237.
Berkow, (1982), The Merck Manual of Diagnosis and Therapy, p. 2383.
White et al., (1978), Principles of Biochemistry, McGraw-Hill, N.Y., pp. 628-630, 1327-1328.
Ralph et al., (Apr. 1, 1987), Cell. Immunol., 105(2):270-279 (abstract only).
Nakoinz et al., (Oct. 15, 1988), Cell. Immunol., 116(2):331-340 (abstract only).
Sampson-Johannes et al., (Nov. 15, 1988), J. Immunol., 141(10):3680-3686.
Wing et al., (1982), J. Clin. Invest., 69:270-276.
Li et al., (Mar. 1989), J. Exp. Med., 169:973-986.
Motoyoshi et al., (1989), Lancet, vol. II, (No. 8658):326-327.
Stoudemire et al., (Feb. 15, 1991), Blood, 77(4):750-755.
Dexter et al., (1984), Nature, 309:746-747.
Andreeff et al., (Jun. 1989), Sem Oncol., 16(3):211-229.
Nadler, (1990), Cancer Invest., 8(2):299-300.
Wang et al., (1983), J. Cell. Biochem., 21:263-275.
Kawashima Takuji
Motoyoshi Kazuo
Suzu Shinya
Takaku Fumimaro
Ujiie Kunio
Hendricks Keith D.
Morinaga Milk Industry Co. Ltd.
Wax Robert A.
LandOfFree
Human monocyte-macrophage-CSF preparations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human monocyte-macrophage-CSF preparations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human monocyte-macrophage-CSF preparations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-169293